Avantor Inc (AVTR)
20.56
+0.20
(+0.98%)
USD |
NYSE |
Nov 22, 10:37
Avantor Enterprise Value: 18.49B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 18.49B |
| November 20, 2024 | 18.34B |
| November 19, 2024 | 18.06B |
| November 18, 2024 | 18.37B |
| November 15, 2024 | 18.75B |
| November 14, 2024 | 19.03B |
| November 13, 2024 | 19.32B |
| November 12, 2024 | 19.47B |
| November 11, 2024 | 19.81B |
| November 08, 2024 | 20.01B |
| November 07, 2024 | 20.28B |
| November 06, 2024 | 20.27B |
| November 05, 2024 | 20.13B |
| November 04, 2024 | 19.98B |
| November 01, 2024 | 19.82B |
| October 31, 2024 | 19.86B |
| October 30, 2024 | 19.92B |
| October 29, 2024 | 19.96B |
| October 28, 2024 | 20.04B |
| October 25, 2024 | 19.90B |
| October 24, 2024 | 20.47B |
| October 23, 2024 | 20.78B |
| October 22, 2024 | 20.90B |
| October 21, 2024 | 21.30B |
| October 18, 2024 | 21.47B |
| Date | Value |
|---|---|
| October 17, 2024 | 21.49B |
| October 16, 2024 | 21.51B |
| October 15, 2024 | 21.57B |
| October 14, 2024 | 21.69B |
| October 11, 2024 | 21.48B |
| October 10, 2024 | 21.29B |
| October 09, 2024 | 21.49B |
| October 08, 2024 | 21.51B |
| October 07, 2024 | 21.64B |
| October 04, 2024 | 21.86B |
| October 03, 2024 | 21.74B |
| October 02, 2024 | 22.02B |
| October 01, 2024 | 21.94B |
| September 30, 2024 | 22.24B |
| September 27, 2024 | 22.40B |
| September 26, 2024 | 22.56B |
| September 25, 2024 | 22.29B |
| September 24, 2024 | 22.89B |
| September 23, 2024 | 22.91B |
| September 20, 2024 | 23.19B |
| September 19, 2024 | 23.67B |
| September 18, 2024 | 23.24B |
| September 17, 2024 | 23.11B |
| September 16, 2024 | 23.33B |
| September 13, 2024 | 23.12B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.67B
Minimum
Mar 18 2020
33.42B
Maximum
Dec 31 2021
21.86B
Average
21.21B
Median
Feb 01 2024
Enterprise Value Benchmarks
| Bruker Corp | 10.71B |
| Azenta Inc | 1.613B |
| Harvard Bioscience Inc | 127.50M |
| Bionano Genomics Inc | 14.35M |
| Akoya Biosciences Inc | 145.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 57.80M |
| Revenue (Quarterly) | 1.714B |
| Total Expenses (Quarterly) | 1.590B |
| EPS Diluted (Quarterly) | 0.08 |
| Gross Profit Margin (Quarterly) | 32.92% |
| Profit Margin (Quarterly) | 3.37% |
| Earnings Yield | 2.19% |
| Operating Earnings Yield | 4.50% |
| Normalized Earnings Yield | 2.216 |